M. Gibaldi

M. Gibaldi, M. Schwartz, M. Plaut, 1970, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology.

Route of administration and drug metabolism.

M. Gibaldi, S. Feldman, 1972, European journal of pharmacology.

Effect of coadministered salicylamide on terbutaline metabolism in rats.

M. Gibaldi, S. Singhvi, W. Conway, 1977, Journal of pharmaceutical sciences.

Absorption Kinetics and Bioavailability

M. Gibaldi, D. Perrier, 1982 .

Gene and Cell Therapy

M. Gibaldi, R. Ho, 2013 .

INTEGRATION OF DISCOVERY AND DEVELOPMENT

M. Gibaldi, R. Ho, 2013 .

Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.

M. Gibaldi, S. Feldman, 1969, Journal of pharmaceutical sciences.

Multicompartment pharmacokinetic models and pharmacologic effects.

G Levy, W J Jusko, M Gibaldi, 1969, Journal of pharmaceutical sciences.

ADVANCES IN PERSONALIZED MEDICINE: Pharmacogenetics in Drug Therapy

M. Gibaldi, R. Ho, 2013 .

Regulating Angiogenesis: A New Therapeutic Strategy

M. Gibaldi, 1998, Journal of clinical pharmacology.

Pharmacokinetics of drug action.

G Levy, M Gibaldi, M. Gibaldi, 1972, Annual review of pharmacology.

Dose-dependent decline of pharmacologic effects of drugs with linear pharmacokinetic characteristics.

M. Gibaldi, G. Levy, Milo Gibaldi, 1972, Journal of pharmaceutical sciences.

Tubocurarine and renal failure.

M. Gibaldi, W. Hayton, G. Levy, 1972, British journal of anaesthesia.

Drug transport. VI. Functional integrity of the rat everted small intestine with respect to passive transfer.

M. Gibaldi, B. Grundhofer, 1972, Journal of pharmaceutical sciences.

Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics

P. McNamara, M. Gibaldi, J. Slattery, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding II. Physiological significance

P. McNamara, M. Gibaldi, K. Stoeckel, 2004, European Journal of Clinical Pharmacology.

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding I. Theoretical considerations

P. McNamara, M. Gibaldi, K. Stoeckel, 2004, European Journal of Clinical Pharmacology.

Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

M. Gibaldi, D. Perrier, 1974, The Journal of pharmacology and experimental therapeutics.

Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.

M Gibaldi, M. Gibaldi, L. Harrison, 1977, Journal of pharmaceutical sciences.

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma

P. McNamara, M. Gibaldi, G. Levy, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

Adverse Drug Effect—Reactive Metabolites and Idiosyncratic Drug Reactions: Part I

M. Gibaldi, 1992, The Annals of pharmacotherapy.

Helicobacter pylori and Gastrointestinal Disease

M. Gibaldi, 1995, Journal of clinical pharmacology.

Serum creatinine and drug half-lives in renal failure.

M. Gibaldi, D. Perrier, 1972, JAMA.

Bile flow in the rat after enteral administration of bile salts

M. Gibaldi, C. Nightingale, 1969, The American Journal of Digestive Diseases.

Effect of glucosamine on urinary excretion of salicylate.

M. Gibaldi, J. Kanig, 1965, Journal of pharmaceutical sciences.

Plasma protein binding and metabolic clearance of phenytoin in the rat.

M. Gibaldi, W. Colburn, 1977, The Journal of pharmacology and experimental therapeutics.

Dissolution rates in surfactant solutions under stirred and static conditions.

N. Weiner, M. Gibaldi, S. Feldman, 1968, Journal of pharmaceutical sciences.

Dissolution of salicylic acid and polyvinylpyrrolidone from compressed mixtures.

M. Gibaldi, H. Weintraub, 1968, Journal of pharmaceutical sciences.

Rotating-flask method for dissolution-rate determinations of aspirin from various dosage forms.

M. Gibaldi, H. Weintraub, 1970, Journal of pharmaceutical sciences.

Effect of sodium deoxycholate on gastric emptying in the rat.

M. Gibaldi, S. Feldman, R. Wynn, 1968, Journal of Pharmacy and Science.

Problem in the estimation of drugs in biologic tissue recovery of phenol red from the GI tract.

M. Gibaldi, S. Feldman, 1968, Journal of pharmaceutical sciences.

Effect of bile salts on gastric emptying and intestinal transit in the rat.

M. Gibaldi, S. Feldman, 1968, Gastroenterology.

Bioequivalence of thyroid preparations: The final word?

M. Gibaldi, 2005, The AAPS Journal.

Enhancement of intestinal absorption of a quaternary ammonium compound by salicylate and trichloroacetate.

M. Gibaldi, B. Grundhofer, 1973, Journal of pharmaceutical sciences.

Time course and dose dependence of antacid effect on urine pH.

M. Gibaldi, G. Levy, B. Grundhofer, 1975, Journal of pharmaceutical sciences.

Physiologic surface-active agents and drug absorption. VII. Effect of sodium deoxycholate on phenol red absorption in the rat.

M. Gibaldi, S. Feldman, M. Salvino, 1970, Journal of pharmaceutical sciences.

Bile salt enhancement of riboflavin and flavin mononucleotide absorption in man.

M. Gibaldi, M. Mayersohn, S. Feldman, 1969, The Journal of nutrition.

Physiologic surface-active agents and drug absorption. 3. Effect of bile salt on drug absorption in goldfish.

M. Gibaldi, C. Nightingale, R. Wynn, 1969, Journal of pharmaceutical sciences.

Handbook of clinical pharmacokinetics

M. Gibaldi, L. Prescott, 1983 .

Revisiting Some Factors Contributing to Variability

M. Gibaldi, 1992, The Annals of pharmacotherapy.

Ethnic Differences in the Assessment and Treatment of Disease

M. Gibaldi, 1993, Pharmacotherapy.

Pharmacogenetics: Part II

M. Gibaldi, 2007 .

Prevention and Treatment of Osteoporosis: Does the Future Belong to Hormone Replacement Therapy?

M. Gibaldi, 1997, Journal of clinical pharmacology.

Pharmacokinetics of bethanidine in hypertensive patients

M. Gibaldi, J. McNay, P. Dayton, 1975, Clinical pharmacology and therapeutics.

Bile Salt-Induced Permeability Changes in the Isolated Rat Intestine 1

M. Gibaldi, S. Feldman, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Comparison of observed and predicted bioavailability of nortriptyline in humans following oral administration.

M. Gibaldi, 1975, Journal of pharmaceutical sciences.

Prediction of systemic availability from plasma‐level data after oral drug administration

M. Gibaldi, D. Perrier, R. Boyes, 1973, The Journal of pharmacy and pharmacology.

Influence of first-pass effect on the systemic availability of propoxyphene.

M. Gibaldi, D. Perrier, 1972, The Journal of clinical pharmacology and new drugs.

ADVANCED DRUG DELIVERY

Rodney J. Y. Ho, Milo Gibaldi, M. Gibaldi, 2004 .

Influence of cholestasis on drug elimination: pharmacokinetics.

M. Gibaldi, L. Harrison, 1976, Journal of pharmaceutical sciences.

Rectal absorption from aspirin suppositories in children and adults.

M. Gibaldi, M. Nowak, B. Brundhofer, 1974, Pediatrics.

Interaction of chloramphenicol with phenytoin and phenobarbital; Case report

M. Gibaldi, W. Colburn, P. Mcnamara, 1978, Clinical pharmacology and therapeutics.

Pharmacokinetics in clinical practice. 2. Applications.

M. Gibaldi, G. Levy, 1976, JAMA.

Effect of mode of administration on drug distribution in a two-compartment open system.

M. Gibaldi, 1969, Journal of pharmaceutical sciences.

Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing

M. Gibaldi, D. Perrier, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

Drug Concentrations in the Plasma as an Index of Pharmacologic Effect

M. Gibaldi, D. Perrier, 1974, Journal of clinical pharmacology.

Introduction to biopharmaceutics

M. Gibaldi, 1971 .

Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration

Wayne A. Colburn, Daniel Shen, Milo Gibaldi, 1976, Journal of Pharmacokinetics and Biopharmaceutics.

Correlation of pharmacologic activity and dissolution rates of reserpine-desoxycholic acid dispersions.

M. Gibaldi, T. R. Bates, S. Feldman, 1968, Journal of pharmaceutical sciences.

Absorption and excretion of riboflavin in the rat: an unusual example of nonlinear pharmacokinetics.

M. Gibaldi, J. Axelson, 1972, Journal of pharmaceutical sciences.

Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates.

M. Gibaldi, K. C. Khoo, R. Brazzell, 1985, Journal of pharmaceutical sciences.

Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.

M. Gibaldi, A. Mclean, P. du Souich, 1978, Journal of pharmaceutical sciences.

Assessment of drug absorption after oral administration.

M Gibaldi, M. Gibaldi, K. Chan, 1985, Journal of pharmaceutical sciences.

Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function.

M. Gibaldi, K. Chan, F. Langenbucher, 1987, Journal of pharmaceutical sciences.

APPLICATION OF BIOTECHNOLOGY IN DRUG DISCOVERY AND EARLY DEVELOPMENT

M. Gibaldi, R. Ho, 2013 .

Hypothesis for the Individualisation of Drug Dosage

A L Smith, J R Koup, M Gibaldi, 1979, Clinical pharmacokinetics.

Meta-Analysis

M. Gibaldi, 1993, Drugs.

Individualization of theophylline dosage using a single serum sample following a test dose.

W. Pierson, M. Gibaldi, G. Shapiro, 1982, Pediatrics.

Rapid Estimation of Chloramphenicol Clearance in Infants and Children

M. Gibaldi, Arnold L. Smith, Jeffrey R. Koup, 1981, Clinical Pharmacokinetics.

Single point clearance estimation.

M. Gibaldi, J. Slattery, J. Koup, 1979, Research communications in chemical pathology and pharmacology.

Steady-state concentrations of drugs with short half-lives when administered in oral sustained release formulations

P. McNamara, M. Gibaldi, 1979 .

Plasma protein binding of diazepam after a single dose of sodium oleate.

M. Gibaldi, W. Colburn, 1978, Journal of pharmaceutical sciences.

Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.

M. Gibaldi, W. Trager, A. Rettie, 1989, Drug metabolism and disposition: the biological fate of chemicals.

Route of administration and drug disposition.

M. Gibaldi, D. Perrier, 1974, Drug metabolism reviews.

Failure to Comply: A Therapeutic Dilemma and the Bane of Clinical Trials

M. Gibaldi, 1996, Journal of clinical pharmacology.

Bioavailability of Drugs Focus on Digoxin DURING

M. Gibaldi, G. Levy, 2005 .

Pharmacokinetics of Erythromycin on Repetitive Dosing

M. Gibaldi, W. Colburn, ANTHONY R. Santo, 1977, Journal of clinical pharmacology.

Calculation of absorption rate constants for drugs with incomplete availability.

M. Gibaldi, D. Perrier, 1973, Journal of Pharmacy and Science.

CRITICAL IN VITRO FACTORS IN EVALUATION OF GASTRIC ANTACIDS. I. POLYPEPTIDE INHIBITION.

M. Gibaldi, J. Kanig, S. Desai, 1963, Journal of Pharmacy and Science.

Drug Interactions: Part I

M. Gibaldi, 1992, The Annals of pharmacotherapy.

Influence of long‐term infusions on lidocaine kinetics

J. P. Shea, M. Gibaldi, L. Bauer, 1982, Clinical pharmacology and therapy.

Anatomy of an Antibody, and Related Misadventures in Developing an Effective Treatment for Septic Shock

M. Gibaldi, 1993, Pharmacotherapy.

Apparent Volume of Distribution

M. Gibaldi, D. Perrier, 1982 .

Absorption, metabolism and excretion of N, N-bis(phenylcarbamoylmethyl) dimethylammonium chloride (QX-572) in the rat.

M. Gibaldi, J. Axelson, W. Conway, 1974, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics of Absorption and Elimination of Doxycycline in Man

M. Gibaldi, 1967 .

Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease—a hypothesis

M. Gibaldi, A. Mclean, P. Souich, 1979, Clinical pharmacology and therapeutics.

Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate.

M. Gibaldi, W. Colburn, 1978, Drug metabolism and disposition: the biological fate of chemicals.

Drug elimination and apparent volume of distribution in multicompartment systems.

M. Gibaldi, D. Perrier, 1972, Journal of pharmaceutical sciences.

Method for Determining Dissolution Rates of Multiparticulate Systems

M. Gibaldi, J. Shanker, J. Kanig, 1965 .

Hydrodynamic and Diffusional Considerations in Assessing the Effects of Surface Active Agents on the Dissolution Rate of Drugs

N. Weiner, M. Gibaldi, S. Feldman, 1970 .

Physiologic surface-active agents and drug absorption II. Comparison of the effect of sodium taurodeoxycholate and ethylenediaminetetraacetic acid on salicylamide and salicylate transfer across the everted rat small intestine.

M. Gibaldi, S. Feldman, 1969, Journal of pharmaceutical sciences.

Human Gene Therapy

M. Gibaldi, 1993 .

Pharmacokinetics of Erythromycin in Normal and Alcoholic Liver Disease Subjects

M. Gibaldi, T. R. Bates, K. W. Hall, 1982, Journal of clinical pharmacology.

Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs

M. Gibaldi, R. Ho, 2003 .

Pharmacogenetics: Part I

M. Gibaldi, Milo Gibaldi, 2007 .

Fitting concentration-time data to biexponential equations

M. Gibaldi, W. Colburn, Doris Wong, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

CLINICAL EVALUATION AND REGULATORY APPROVAL AND ENFORCEMENT OF BIOPHARMACEUTICALS

M. Gibaldi, R. Ho, 2013 .

Pharmacogenetics: Part I

M. Gibaldi, 1992, The Annals of Pharmacotherapy.

A Look at Cost‐Effectiveness

M. Gibaldi, S. Sullivan, Milo Gibaldi, 1994, Pharmacotherapy.